Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Efficacy of Simvastatin for the Treatment of COPD [Phase 3]
A Phase 3 trial evaluating the efficacy of simvastatin for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: 28-day Repeat Dose Study of GSK573719 [Phase 2]
A Phase 2 28-day repeat-dose study of GSK573719 in chronic obstructive pulmonary disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 study comparing the combination GSK573719/GW642444 to GSK573719 alone and to tiotropium in chronic obstructive pulmonary disease h…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Home Mechanical Ventilation Effectiveness and Air Leaks
A completed clinical trial evaluated the effectiveness of home mechanical ventilation and issues with air leaks in patients with chronic res…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Airflow Limitation in Cardiac Diseases in Europe
GlaxoSmithKline-sponsored European trial evaluating airflow limitation in chronic obstructive pulmonary disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting
The trial update reports that inflammatory biomarkers may predict pulmonary outcomes in patients undergoing coronary artery bypass grafting.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Improving Monitoring of Patients Receiving Case Management
A completed clinical trial update evaluating improved monitoring for patients receiving case management across multiple conditions, includin…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days [Phase 2]
A Phase 2 study assessing safety and tolerability of once-daily inhaled GSK573719 (formulated with magnesium stearate) in COPD patients over…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the combination inhaler QVA149A versus concurrent administration of QAB149 and NVA237 in…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: HELPing Older People With Very Severe Chronic Obstructive Pulmonary Disease Towards the End of Their Lives: Developing, Piloting and Refining a Practical Intervention (HELP-COPD) [EARLY_Phase 1]
Early Phase 1 trial of the HELP-COPD intervention to support end-of-life care for older people with very severe COPD has been developed, pil…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease
A completed clinical trial evaluated whether measuring fractional exhaled nitric oxide (FeNO) could identify eosinophilic airway inflammatio…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg [Phase 3]
A Phase 3 cross-over study in COPD evaluated lung function after treatment with umeclidinium, vilanterol, and the umeclidinium/vilanterol co…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled crossover dose-ranging study evaluated the dose response of GSK573719 in chronic obst…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD [Phase 3]
Phase 3 trial evaluating the efficacy and safety of GSK573719 delivered via a novel dry powder inhaler in chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A phase 3 cross-over study evaluated lung function response after treatment with umeclidinium, vilanterol, and umeclidinium/vilanterol in CO…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Feasibility of Strength Training in Patients Hospitalized Due to COPD [NA]
A completed study evaluating the feasibility of strength training for patients hospitalized with chronic obstructive pulmonary disease, incl…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD [Phase 3]
A Phase 3 trial evaluating GSK573719/Vilanterol (125/25 mcg) and components in COPD completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial comparing GSK573719/GW642444 with GW642444 and with tiotropium in chronic obstructive pulmonary disease has completed; results…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of the combination of GSK573719 and GW642444 i…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A [Phase 3]
A Phase 3 COPD trial (Study A) evaluating the dual bronchodilator GSK573719/GW642444 has completed and its results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Outlook: An Intervention to Improve Quality of Life in Serious Illness [NA]
A Duke University study evaluating an intervention to improve quality of life in seriously ill patients has completed, covering cancer, chro…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing once-daily Fluticasone Furoate/Vilanterol to twice-daily Fluticasone Propionate/Salmeterol in COPD; completed with r…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Trial of Vitamin D Supplementation in Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]
Clinical trial update noting the completion of a Phase 2/Phase 3 trial of Vitamin D supplementation in Chronic Obstructive Pulmonary Disease…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Effects of Salmeterol on Autonomic Nervous System [Phase 4]
Phase 4 clinical trial assessing the effects of salmeterol on the autonomic nervous system in chronic obstructive pulmonary disease; results…
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Evaluation of Muscle Activation Efficiency in Challenging Subjects [NA]
A completed clinical trial update from Niveus Medical evaluating muscle activation efficiency in subjects with obesity and chronic obstructi…